HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A new ceramide from Suillus luteus and its cytotoxic activity against human melanoma cells.

Abstract
A new phytosphingosine-type ceramide, suillumide (1), was isolated from the EtOH extract of the basidiomycete Suillus luteus (L.) S. F. Gray, along with ten known compounds: ergosta-4,6,8(14),22-tetraen-3-one, ergosterol, ergosterol peroxide, suillin, (E)-3,4,5-trimethoxycinnamic alcohol, 5 alpha,6 alpha-epoxyergosta-8,22-diene-3beta,7 beta-diol, (R)-1-palmitoylglycerol, ergosta-7,9(11),22-triene-3beta,5 alpha,6 beta-triol, cerevisterol, and 4-hydroxybenzoic acid. The structure of 1 was determined on the basis of spectroscopic and mass-spectrometric analyses, as well as by chemical methods. Compound 1 and its synthetic diacetyl derivative 2 were tested for their cytotoxic activities against the human melanoma cell line SK-MEL-1. Both drugs showed IC(50) values of ca. 10 microM after 72 h of exposure.
AuthorsFrancisco León, Ignacio Brouard, Fernando Torres, José Quintana, Augusto Rivera, Francisco Estévez, Jaime Bermejo
JournalChemistry & biodiversity (Chem Biodivers) Vol. 5 Issue 1 Pg. 120-5 (Jan 2008) ISSN: 1612-1880 [Electronic] Switzerland
PMID18205114 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antineoplastic Agents
  • Ceramides
  • Furans
  • N-(5-dodecyl-4-hydroxytetrahydrofuran-3-yl)-2-hydroxyheptadecanamide
Topics
  • Antineoplastic Agents (chemistry, isolation & purification, pharmacology)
  • Basidiomycota (chemistry)
  • Cell Line, Tumor
  • Cell Proliferation (drug effects)
  • Ceramides (chemistry, isolation & purification, pharmacology)
  • Drug Screening Assays, Antitumor
  • Furans (chemistry, isolation & purification, pharmacology)
  • Humans
  • Magnetic Resonance Spectroscopy (methods, standards)
  • Melanoma (drug therapy)
  • Molecular Conformation
  • Reference Standards
  • Spectrophotometry, Infrared (methods)
  • Stereoisomerism
  • Structure-Activity Relationship

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: